To date eleven out of a total of twelve patients are currently available for response evaluation, including two out of three from the 4th and final treatment group.
http://www.businesswire.com/news/home/20131128005382/en/Data-Final-Cohort-Patients-Patrys-Multiple-Myeloma
http://www.businesswire.com/news/home/20131128005382/en/Data-Final-Cohort-Patients-Patrys-Multiple-Myeloma
No comments:
Post a Comment